Tesla halts Shanghai plant expansion as U.S.-China tension intensifies
Category: #headlines  By Nikita Chaurasia  Date: 2021-05-13
  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn

Tesla halts Shanghai plant expansion as U.S.-China tension intensifies

American electric vehicle company Tesla Inc. has reportedly put a halt on its plans to buy land for the expansion of its Shanghai plant, due to the emerging uncertainties brought forth by rising political tensions between the U.S. and -China.

The EV maker intends to slash the proportion of Chinese output from its global production volumes, considering the 25% levy on imported electric vehicles from China plus other existing tariffs in the U.S, according to sources.

Tesla desisted from participating in the bidding round for a plot of land situated close to its existing plant during March 2021, as it no longer plans to boost production capacity in China, cited sources close to the company.

The company is reportedly using some of the land designed for production as a parking space, at the Shanghai site. One of the sources also revealed that Tesla has enough property to expand its capacity beyond 500,000 in the existing plant itself.

Notably, the automaker has been shipping its China-manufactured Model 3 to Europe, where it is setting up a plant in Germany, and had previously considered increasing its exports of Chinese entry-level Model 3 to newer marketspaces such as the U.S.

The EV maker’s Shanghai factory can reportedly produce up to 500,000 cars every year and is currently manufacturing at a rate of 450,000 Model Y and Model 3 cars per year.

However, the company is now focusing on building facilities for the repair and reproduction of key components such as battery cells and electric motors and to manufacture EV chargers at its Shanghai site.

The Shanghai government has reportedly been in discussion with several companies to sell the land for clean-energy commercial vehicle production.

In other news, the Chinese government recently approved the first official swappable EV battery standard and safety guidelines, implying reduced cost to vehicle buyers, and utilization of varying battery sizes as per the requirement.

Source Link –

https://economictimes.indiatimes.com/news/international/business/tesla-puts-brake-on-shanghai-land-buy-as-us-china-tensions-weigh-sources/articleshow/82550641.cms

 

  • shareshare_icon
  • Twitter
  • Facebook
  • LinkedIn


About Author

Nikita Chaurasia     twitter

Nikita Chaurasia

Having always been daft at wordplay, Nikita Chaurasia, post the completion of post-graduation, commenced her journey into the content generation cosmos. Endowed with a professional MBA degree in Advertising and Public Relations, Nikita strives to integrate her creativ...

Read More..

More News By Nikita Chaurasia

Coretec Group, Eindhoven University join hands for research works

Coretec Group, Eindhoven University join hands for research works

By Nikita Chaurasia

U.S.-based new silicon products pioneer Coretec Group Inc. has reportedly entered into a research partnership with Eindhoven University of Technology (TU/e), which is among the leading 50 universities in engineering and technology globally as per QS ...

FedEx partners with Nuro to develop autonomous package delivery systems

FedEx partners with Nuro to develop autonomous package delivery systems

By Nikita Chaurasia

FedEx Corporation and robotics startup Nuro have reportedly signed a multi-year agreement to develop and test last-mile delivery using autonomous vehicles. The American multinational delivery giant will be using its Houston facility for the pilot pro...

Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug

Breckenridge Pharmaceutical receives FDA approval for anti-cancer drug

By Nikita Chaurasia

According to reliable sources, Natco Pharma’s marketing partner Breckenridge Pharmaceutical Inc. has obtained approval from U.S. Food and Drug Administration (USFDA), for its anti-cancer drug Carfilzomib Vials. For the record, Carfilzomib Vial...